Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Tango Therapeutics, Inc.
Tango Therapeutics, Inc.
Instituto do Cancer do Estado de São Paulo
Genmab
KaliVir Immunotherapeutics
Beijing Biotech
IDEAYA Biosciences
Vivace Therapeutics, Inc
AstraZeneca
National Institutes of Health Clinical Center (CC)
Nuvectis Pharma, Inc.
A2 Biotherapeutics Inc.
National Institutes of Health Clinical Center (CC)
University of Chicago
Perspective Therapeutics
VM Oncology, LLC
Dana-Farber Cancer Institute
Bristol-Myers Squibb
Brigham and Women's Hospital
Dana-Farber Cancer Institute
Brigham and Women's Hospital
Baylor College of Medicine
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of Pittsburgh
University of Chicago
National and Kapodistrian University of Athens
Gruppo Oncologico Italiano di Ricerca Clinica
BridGene Biosciences Inc.
NHS Greater Glasgow and Clyde
Second Affiliated Hospital of Guangzhou Medical University
A&G Pharmaceutical Inc.